Baker DW, Wolf MS, Feinglass J, Thompson JA Health literacy, cognitive abilities, and mortality among elderly persons. J Gen Intern Med. 2008 Jun;23(6):723-6. doi: 10.1007/s11606-008-0566-4. Epub 2008 Mar 11.
Castro CM, Wilson C, Wang F, Schillinger D Babel babble: physicians' use of unclarified medical jargon with patients. Am J Health Behav. 2007 Sep-Oct;31 Suppl 1:S85-95.
Houts PS, Doak CC, Doak LG, Loscalzo MJ The role of pictures in improving health communication: a review of research on attention, comprehension, recall, and adherence. Patient Educ Couns. 2006 May;61(2):173-90. Epub 2005 Aug 24. Review. Erratum in: Patient Educ Couns. 2006 Dec;64(1-3):393-4.
Levinthal BR, Morrow DG, Tu W, Wu J, Murray MD Cognition and health literacy in patients with hypertension. J Gen Intern Med. 2008 Aug;23(8):1172-6. doi: 10.1007/s11606-008-0612-2. Epub 2008 May 6.
Makoul G Essential elements of communication in medical encounters: the Kalamazoo consensus statement. Acad Med. 2001 Apr;76(4):390-3. Review.
Morrow D Improving consultations between health-care professionals and older clients: implications for pharmacists. Int J Aging Hum Dev. 1997;44(1):47-72. Review.
Morrow DG, Hier CM, Menard WE, Leirer VO Icons improve older and younger adults' comprehension of medication information. J Gerontol B Psychol Sci Soc Sci. 1998 Jul;53(4):P240-54.
Morrow DG, Rogers WA Environmental support: an integrative framework. Hum Factors. 2008 Aug;50(4):589-613. Review.
Morrow DG, Weiner M, Steinley D, Young J, Murray MD Patients' health literacy and experience with instructions: influence preferences for heart failure medication instructions. J Aging Health. 2007 Aug;19(4):575-93.
Parker RM, Wolf MS, Kirsch I Preparing for an epidemic of limited health literacy: weathering the perfect storm. J Gen Intern Med. 2008 Aug;23(8):1273-6. doi: 10.1007/s11606-008-0621-1. Epub 2008 May 2.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.